What does CUSIP 75943R102 represent in this 13F holders report?

CUSIP 75943R102 is the security identifier for RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value used to aggregate holder disclosures.

How many institutions held RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value in Q4 2022?

163 institutional investors reported RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value for Q4 2022. Use the holders table for investor-level position and value details.

Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY)

CUSIP: 75943R102

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock, $0.01 par value
Shares outstanding: 4,389,099
Total 13F shares: 128,192,171
Share change: +4,730,717
Total reported value: $1,915,159,649
Put/Call ratio: 0.2%
Price per share: $14.94
Number of holders: 163
Value change: +$58,936,160
Number of buys: 102
Number of sells: 55

Quarterly Holders Quick Answers

What is CUSIP 75943R102?
CUSIP 75943R102 identifies RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 75943R102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SB INVESTMENT ADVISERS (UK) LTD	13F	Company	636%	27,904,963	$624,234,000	—	30 Sep 2022	13F
FMR LLC	13F	Company	272%	11,958,212	$267,505,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	190%	8,359,520	$187,003,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	154%	6,757,637	$151,169,000	—	30 Sep 2022	13F
JPMORGAN CHASE & CO	13F	Company	114%	5,018,487	$112,263,000	—	30 Sep 2022	13F
Casdin Capital, LLC	13F	Company	107%	4,683,432	$104,768,000	—	30 Sep 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	104%	4,561,363	$102,039,000	—	30 Sep 2022	13F
BVF INC/IL	13F	Company	99%	4,339,521	$97,075,000	—	30 Sep 2022	13F
Bellevue Group AG	13F	Company	96%	4,204,820	$94,062,000	—	30 Sep 2022	13F
EcoR1 Capital, LLC	13F	Company	95%	4,163,824	$93,145,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	84%	3,668,070	$82,055,000	—	30 Sep 2022	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	68%	2,967,445	$66,382,000	—	30 Sep 2022	13F
ArrowMark Colorado Holdings LLC	13F	Company	57%	2,512,468	$56,204,000	—	30 Sep 2022	13F
Boxer Capital, LLC	13F	Company	49%	2,169,132	$48,523,000	—	30 Sep 2022	13F
PERCEPTIVE ADVISORS LLC	13F	Company	44%	1,943,097	$43,467,000	—	30 Sep 2022	13F
T. Rowe Price Investment Management, Inc.	13F	Company	41%	1,811,603	$40,526,000	—	30 Sep 2022	13F
NORGES BANK	13F	Company	39%	1,730,687	$38,715,468	—	30 Sep 2022	13F
Alphabet Inc.	13F	Company	36%	1,568,753	$35,093,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	35%	1,550,975	$34,695,000	—	30 Sep 2022	13F
Artal Group S.A.	13F	Company	33%	1,454,716	$32,542,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	32%	1,426,303	$31,906,000	—	30 Sep 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	32%	1,403,425	$31,395,000	—	30 Sep 2022	13F
S.c.a. Candriam	13F	Individual	26%	1,159,421	$25,938,000	—	30 Sep 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	19%	829,560	$18,557,257	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	19%	817,835	$18,294,000	—	30 Sep 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	16%	717,618	$16,053,000	—	30 Sep 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	15%	658,385	$14,728,000	—	30 Sep 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	14%	635,607	$14,220,000	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	14%	618,967	$13,847,000	—	30 Sep 2022	13F
Rock Springs Capital Management LP	13F	Company	14%	618,267	$13,831,000	—	30 Sep 2022	13F
Integral Health Asset Management, LLC	13F	Company	14%	600,000	$13,422,000	—	30 Sep 2022	13F
BESSEMER GROUP INC	13F	Company	13%	584,463	$13,074,000	—	30 Sep 2022	13F
HARVARD MANAGEMENT CO INC	13F	Company	12%	541,124	$12,105,000	—	30 Sep 2022	13F
Nextech Invest Ltd.	13F	Company	11%	475,485	$10,637,000	—	30 Sep 2022	13F
BAILLIE GIFFORD & CO	13F	Company	9.2%	404,620	$9,051,000	—	30 Sep 2022	13F
Avoro Capital Advisors LLC	13F	Company	9.1%	400,000	$8,948,000	—	30 Sep 2022	13F
DEUTSCHE BANK AG\	13F	Company	8.9%	390,108	$8,726,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	7.8%	342,341	$7,658,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	7.8%	342,252	$7,656,000	—	30 Sep 2022	13F
Woodline Partners LP	13F	Company	7.6%	331,663	$7,419,000	—	30 Sep 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	7.1%	312,584	$6,993,000	—	30 Sep 2022	13F
Artisan Partners Limited Partnership	13F	Company	7%	305,626	$6,837,000	—	30 Sep 2022	13F
Sessa Capital IM, L.P.	13F	Company	6.9%	301,200	$6,738,000	—	30 Sep 2022	13F
HARBOURVEST PARTNERS LLC	13F	Company	6.8%	296,402	$6,631,000	—	30 Sep 2022	13F
Ghisallo Capital Management LLC	13F	Company	6.3%	274,773	$6,147,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	6.2%	274,178	$6,133,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	5.8%	252,740	$5,654,000	—	30 Sep 2022	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	5%	219,035	$4,900,000	—	30 Sep 2022	13F
Rafferty Asset Management, LLC	13F	Company	4.5%	196,119	$4,387,000	—	30 Sep 2022	13F
Fernwood Investment Management, LLC	13F	Company	4.2%	185,063	$4,140,000	—	30 Sep 2022	13F

Institutional Holders of Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) as of Q4 2022

As of 31 Dec 2022, Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) was held by 163 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 128,192,171 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, Bellevue Group AG, EcoR1 Capital, LLC, and BVF INC/IL. This page lists 163 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

153

Q4 2022 holders

163

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.